Spravato® REMS requirements,
explained in plain language.
Spravato® (esketamine) is dispensed and administered under one of the stricter Risk Evaluation and Mitigation Strategy programs in outpatient medicine. Here's what the program actually asks of a clinic — certification, enrollment, monitoring, and documentation — without the jargon.
Updated June 12, 2026
The four pillars of compliance
Everything the program asks reduces to four obligations. If you read nothing else, read these; the rest of this guide is why they exist and what they cost to run.
- Certified setting. The clinic (and its pharmacy channel) must be certified with the REMS program before any product is dispensed or administered. Certification carries obligations — trained staff, monitoring capability, and documentation — that the program can audit.
- Enrolled patients. Every patient is enrolled in the REMS before their first treatment, acknowledging the monitoring requirements and the restriction on driving until the next day, after a restful sleep.
- The supervised, monitored session. The patient self-administers the nasal spray under supervision, then remains on site for monitoring — at least two hours — until they're clinically stable to leave with their arranged ride home.
- The Patient Monitoring Form. Each session is documented on the program's monitoring form — vitals, observations, any serious adverse events — and submitted to the REMS program within seven calendar days.
Why Spravato® has a REMS at all
Esketamine carries real, well-characterized risks in the hours after a dose — sedation, dissociation, and blood-pressure elevation — alongside its potential for misuse. The FDA approved it on the condition that it is never simply handed to a patient: every dose is self-administered under direct supervision in a certified healthcare setting, the patient is monitored on site afterwards, and the session is documented to the REMS program. That bargain — access in exchange for provable supervision — is the entire shape of the program.
It is worth being precise about who carries that bargain, because it is the detail that surprises practices most. The obligation attaches to the setting, not to the individual clinician who happened to run a session. A conscientious nurse and an attentive prescriber do not, between them, make a clinic compliant; the clinic's records do. Staff turn over, memories fade, and the person who could explain an unusual afternoon may have left. What remains is what was written down at the time.
What a certified setting is really attesting to
Certification is often described as paperwork, which undersells it. What a setting attests is that it can do four things reliably, every time, for every patient — not that it did them once to get certified:
- Supervise self-administration. Somebody qualified watches the patient use the device, every device, with the rest the label calls for in between. Not "was available"; watched.
- Monitor for the required period. The full window, on a clock that does not pause for a busy afternoon, with the checkpoints actually performed rather than assumed.
- Document the session. Contemporaneously enough that the record means something later — which is a higher bar than "wrote it up before going home".
- Produce the record on request. The obligation does not end when the form is filed. A setting that filed correctly but cannot now show what it filed is in a worse position than it thinks — which is a separate and testable question from whether the record was made well.
What a treatment day owes the program
On the day itself, the requirements concentrate into a sequence every clinic comes to know by heart: confirm the patient's enrollment and transport home; take pre-dose blood pressure; supervise the dosing, device by device, with the rest the label calls for between devices; start the observation clock; re-check blood pressure around the forty-minute mark and again before discharge; record sedation, dissociation, and any other observations as they happen; review whether anything rose to a serious adverse event; and only then discharge — at least two hours after the dose, to a patient who isn't driving.
None of those steps is individually hard. The difficulty is that they repeat for every room, every session, every day — on a clock that doesn't pause — and that the record of them has to be accurate enough to survive scrutiny later. A misread vital transcribed from a clipboard, a monitoring window cut short by a busy afternoon, or a form that slips past its deadline are all, in the program's eyes, the same thing: a compliance failure by a certified setting.
What the record has to be able to show
A useful way to test any clinic's setup is to imagine being asked, months later, about one ordinary Tuesday. Not an incident — just a Tuesday. Can you show, without reconstructing anything from memory:
- That the patient was enrolled before their first session, rather than shortly afterwards.
- What time the first device was administered, and by whom.
- That the blood-pressure checkpoints happened, with their readings and their times.
- That the monitoring window ran its full length — which means a discharge time, not an assurance.
- Which lot the dose came from, tying the session to a specific carton on your shelf. This is the seam where REMS documentation and controlled-substance recordkeeping meet: the lot number on the monitoring form and the lot number in your ledger are supposed to be the same fact, and in a paper clinic they are two facts that agree by luck.
- That adverse events were reviewed, including the explicit finding that there were none.
- That the form was filed inside seven days, with something better than a memory of having sent it.
Most clinics can answer four or five of those confidently. The ones they hesitate on are almost always the same two: the exact administration time, and proof of filing. Both are by-products of how the day was recorded, which is why the tooling question below is not really a tooling question.
Who does what
- The prescriber determines treatment, handles enrollment, and signs off on clinical judgments — including any decision to dose outside normal parameters.
- The administering clinician (often an RN or NP) runs the session: checklist, vitals, supervised dosing, observations, and the discharge assessment.
- The front desk keeps the floor moving — who's arriving, which room is in which phase, which forms are still unfiled.
- The clinic itself — as the certified setting — owns the obligation. Individual diligence doesn't transfer; the setting's records do.
One assignment is worth making explicit because it is the one most often left implicit: somebody has to own the unfiled queue. Not the filing — the queue. Forms get filed when a named person looks at a list of what has not been filed yet, and orphaned paperwork is how a generous seven-day deadline turns into a missed one.
Paper, spreadsheets, or software
The program doesn't mandate any particular tooling — a clipboard and a phone timer are, formally, compliant instruments. The question is whether they produce a defensible record: timestamps a reviewer can trust, a monitoring window that provably ran its full length, and forms that demonstrably met their deadline. That's the gap purpose-built tooling closes — not by changing what the program asks, but by making the proof a by-product of running the day instead of a second job after it.
Two practical cautions if you go the software route. Anything holding names, vitals or session records is handling PHI, which makes that vendor your business associate under HIPAA and makes a signed Business Associate Agreement non-negotiable before real patient data flows — worth reading how a vendor actually handles PHI rather than taking the badge on the website at face value. And a system that captures the session beautifully but cannot later show you what it filed has solved the pleasant half of the problem.
Related guides
This guide is general operational information, not legal, clinical, or regulatory advice — always defer to the current official SPRAVATO® REMS program materials and your own counsel. SPRAVATO® is a registered trademark of its respective owner. Lucido is an independent product and is not affiliated with, sponsored by, or endorsed by Janssen Pharmaceuticals.